These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30168243)

  • 1. Temporal trends in the proportion of "cure" in children, adolescents, and young adults diagnosed with chronic myeloid leukemia in England: A population-based study.
    Drozdov D; Bonaventure A; Nakata K; Suttorp M; Belot A
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27422. PubMed ID: 30168243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.
    Egan DN; Beppu L; Radich JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):184-9. PubMed ID: 25300870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia.
    Millot F; Maledon N; Guilhot J; Güneş AM; Kalwak K; Suttorp M
    Eur J Cancer; 2019 Jul; 115():17-23. PubMed ID: 31082688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
    Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
    Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008.
    Björkholm M; Ohm L; Eloranta S; Derolf A; Hultcrantz M; Sjöberg J; Andersson T; Höglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
    J Clin Oncol; 2011 Jun; 29(18):2514-20. PubMed ID: 21576640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of children with chronic myeloid leukemia: A population-based cohort study.
    Egan G; Athale U; Johnston D; Pole JD; Silva M; Zorzi A; Alexander S
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28491. PubMed ID: 32589368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study.
    Özen M; Üstün C; Öztürk B; Topçuoğlu P; Arat M; Gündüz M; Atilla E; Bolat G; Arslan Ö; Demirer T; Akan H; İlhan O; Beksaç M; Gürman G; Özcan M
    Turk J Haematol; 2017 Mar; 34(1):16-26. PubMed ID: 27094579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
    Oyekunle A; Zander AR; Binder M; Ayuk F; Zabelina T; Christopeit M; Stübig T; Alchalby H; Schafhausen P; Lellek H; Wolschke C; Müller I; Bacher U; Kröger N
    Ann Hematol; 2013 Apr; 92(4):487-96. PubMed ID: 23250623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
    Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
    Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
    Wu J; Chen Y; Hageman L; Francisco L; Ness EC; Parman M; Kung M; Watson JA; Weisdorf DJ; Snyder DS; McGlave PB; Forman SJ; Arora M; Armenian SH; Bhatia R; Bhatia S
    Cancer; 2019 Nov; 125(22):4033-4042. PubMed ID: 31412155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia-transplantation in the tyrosine kinase era.
    Innes AJ; Apperley JF
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1037-53. PubMed ID: 25459178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis.
    Ohashi K; Nagamura-Inoue T; Nagamura F; Tojo A; Miyamura K; Mori T; Kurokawa M; Taniguchi S; Ishikawa J; Morishima Y; Atsuta Y; Sakamaki H
    Int J Hematol; 2014 Sep; 100(3):296-306. PubMed ID: 25085253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of frontline treatment approach on outcomes of myeloid blast phase CML.
    Saxena K; Jabbour E; Issa G; Sasaki K; Ravandi F; Maiti A; Daver N; Kadia T; DiNardo CD; Konopleva M; Cortes JE; Yilmaz M; Chien K; Pierce S; Kantarjian H; Short NJ
    J Hematol Oncol; 2021 Jun; 14(1):94. PubMed ID: 34130720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
    Lübking A; Dreimane A; Sandin F; Isaksson C; Märkevärn B; Brune M; Ljungman P; Lenhoff S; Stenke L; Höglund M; Richter J; Olsson-Strömberg U
    Bone Marrow Transplant; 2019 Nov; 54(11):1764-1774. PubMed ID: 30962502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Myelogenous Leukemia in Childhood.
    Smith SM; Hijiya N; Sakamoto KM
    Curr Oncol Rep; 2021 Mar; 23(4):40. PubMed ID: 33718985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I.
    Suttorp M; Claviez A; Bader P; Peters C; Gadner H; Ebell W; Dilloo D; Kremens B; Kabisch H; Führer M; Zintl F; Göbel U; Klingebiel T
    Klin Padiatr; 2009; 221(6):351-7. PubMed ID: 19890786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations.
    Jabbour E; Cortes J; Santos FP; Jones D; O'Brien S; Rondon G; Popat U; Giralt S; Kebriaei P; Jones RB; Kantarjian H; Champlin R; de Lima M
    Blood; 2011 Mar; 117(13):3641-7. PubMed ID: 21156844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party.
    Radujkovic A; Dietrich S; Blok HJ; Nagler A; Ayuk F; Finke J; Tischer J; Mayer J; Koc Y; Sorà F; Passweg J; Byrne JL; Jindra P; Veelken JH; Socié G; Maertens J; Schaap N; Stadler M; Itälä-Remes M; Tholouli E; Arat M; Rocha V; Ljungman P; Yakoub-Agha I; Kröger N; Chalandon Y
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2008-2016. PubMed ID: 31271884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.
    Beinortas T; Tavorienė I; Žvirblis T; Gerbutavičius R; Jurgutis M; Griškevičius L
    BMC Cancer; 2016 Mar; 16():198. PubMed ID: 26956037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.